Systemic reactions to allergy skin tests

被引:76
作者
Valyasevi, MA [1 ]
Maddox, DE [1 ]
Li, JTC [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Allergy Res Lab, Rochester, MN 55905 USA
关键词
D O I
10.1016/S1081-1206(10)62624-5
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Skin testing is a common diagnostic tool in allergy. It is considered a safe procedure, although systemic reactions have been reported. Objective: To identify the systemic reaction rates of allergy skin tests and to determine the clinical outcome of such reactions. Method: This retrospective study used a computerized database at the Mayo Clinic to identify patients who developed systemic reactions to skin tests. Altogether 497,656 skin tests were performed on 18,311 patients from January 1992 to June 1997. Skin puncture tests were performed on 16,505 patients. Skin puncture and intradermal skin tests were performed on 1,806 patients. Systemic reactions were evaluated and treated by physicians. Results: There were 6 systemic reactions, an overall rate of 33 systemic reactions per 100,000 skin tests. All six patients had asthma. The systemic reaction rates for latex skin testing was 152 or 228 reactions per 100,000 latex skin tests, to penicillin and antibiotics 72 reactions per 100,000 penicillin and antibiotics skin tests, and to aeroallergens 15 or 23 reactions per 100,000 aeroallergen skin tests. The systemic reaction rate for skin puncture test was 30 reactions per 100,000 skin puncture tests, for skin puncture and intradermal skin tests, the rate was 55 reactions per 100,000 skin puncture and intradermal skin tests. All 6 patients were treated and dismissed within 1 hour after treatment. Conclusion: The systemic reaction rate to skin tests was very low. Systemic reactions were mild and all patients recovered fully within 1 hour.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 16 条
[1]  
*AM AC ALL IMM, 1983, N ENGL J REG ALLERGY, V4, P224
[2]  
Board of Directors of the American Academy of Allergy, 1993, J ALLERGY CLIN IMMUN, V92, P636
[3]   SAFETY OF LATEX PRICK SKIN TESTING IN ALLERGIC PATIENTS [J].
BONNEKOH, B ;
MERK, HF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (19) :2603-2603
[4]   CLINICAL-EXPERIENCE WITH PENICILLIN SKIN TESTING IN A LARGE INNER-CITY STD CLINIC [J].
GADDE, J ;
SPENCE, M ;
WHEELER, B ;
ADKINSON, NF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2456-2463
[5]   SKIN AND SEROLOGIC TESTING IN THE DIAGNOSIS OF LATEX ALLERGY [J].
KELLY, KJ ;
KURUP, V ;
ZACHARISEN, M ;
RESNICK, A ;
FINK, JN .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (06) :1140-1145
[6]  
LIN MS, 1993, ANN ALLERGY, V71, P557
[7]   THE HYMENOPTERA VENOM STUDY .2. SKIN-TEST RESULTS AND SAFETY OF VENOM SKIN TESTING [J].
LOCKEY, RF ;
TURKELTAUB, PC ;
OLIVE, CA ;
BAIRDWARREN, IA ;
OLIVE, ES ;
BUKANTZ, SC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (06) :967-974
[8]   Adverse reactions associated with skin testing and immunotherapy [J].
Lockey, RF .
ALLERGY PROCEEDINGS, 1995, 16 (06) :293-296
[9]   FATALITIES FROM IMMUNOTHERAPY (IT) AND SKIN TESTING (ST) [J].
LOCKEY, RF ;
BENEDICT, LM ;
TURKELTAUB, PC ;
BUKANTZ, SC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (04) :660-677
[10]  
NELSON HA, 1994, ALLERGY PROC, V6, P265